DNLI - Denali Therapeutics Inc.

QQQ $ 476.23 $ 0.57 (0.12 %)

DIA $ 408.41 $ 0.98 (0.24 %)

SPY $ 556.41 $ 1.52 (0.27 %)

TLT $ 98.08 $ 0.14 (0.15 %)

GLD $ 231.48 $ 1.28 (0.56 %)

Previous Close

$ 23.02

Open

$ 22.85

Bid

$ 23.40 x 106

Ask

-- x --

Day's Range

$ 22.85 - $ 23.67

52 Week Range

$ 14.56 - $ 25.24

Volume

862,926

Average Volume

Market Cap

3.89B

Beta (5Y Monthly)

$ 1.28

PE Ratio (TTM)

EPS (TTM)

TBD

Earnings Date

Dividend & Yield

na ($ 0.00)

Last Ex-Dividend

1y Target Est

TBD na

How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In

#	Filing Date	Period End Date	Type
1	08-01-2024	06-30-2024	10-Q
2	05-07-2024	03-31-2024	10-Q
3	02-28-2024	12-31-2023	10-K
4	11-07-2023	09-30-2023	10-Q
5	08-08-2023	06-30-2023	10-Q
6	05-08-2023	03-31-2023	10-Q
7	02-27-2023	12-31-2022	10-K
8	11-03-2022	09-30-2022	10-Q
9	08-08-2022	06-30-2022	10-Q
10	05-05-2022	03-31-2022	10-Q
11	02-28-2022	12-31-2021	10-K
12	11-04-2021	09-30-2021	10-Q
13	08-04-2021	06-30-2021	10-Q
14	05-05-2021	03-31-2021	10-Q
15	02-26-2021	12-31-2020	10-K
16	11-05-2020	09-30-2020	10-Q
17	08-07-2020	06-30-2020	10-Q
18	05-07-2020	03-31-2020	10-Q
19	02-27-2020	12-31-2019	10-K
20	11-06-2019	09-30-2019	10-Q
21	08-06-2019	06-30-2019	10-Q
22	05-08-2019	03-31-2019	10-Q
23	03-12-2019	12-31-2018	10-K
24	11-08-2018	09-30-2018	10-Q
25	08-09-2018	06-30-2018	10-Q
26	05-11-2018	03-31-2018	10-Q
27	03-19-2018	12-31-2017	10-K

Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In

#	Date	Analyst Firm	Upside/Downside	Price Target Change	Rating Change	Current Rating

News
OPINIONS

News

OPINIONS

HC Wainwright & Co. Reiterates Buy on Dena...
08/15/2024 10:44:29

HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $90 price ...

Denali Therapeutics Announces Publication ...
08/14/2024 18:02:03

Denali Therapeutics Inc. (NASDAQ:DNLI), a biopharmaceutical company developing a broad portfolio of product candidates engineer...

HC Wainwright & Co. Maintains Buy on Denal...
08/05/2024 19:31:07

HC Wainwright & Co. analyst Andrew Fein maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price targ...

Citigroup Maintains Buy on Denali Therapeu...
08/02/2024 16:17:47

Citigroup analyst David Hoang maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and raises the price target from $26 to...

Wedbush Maintains Outperform on Denali The...
08/02/2024 13:53:23

Wedbush analyst Laura Chico maintains Denali Therapeutics (NASDAQ:DNLI) with a Outperform and lowers the price target from $...

Denali Therapeutics Q2 2024 GAAP EPS $(0.5...
08/01/2024 11:25:44

JP Morgan Maintains Overweight on Denali T...
07/10/2024 16:26:36

JP Morgan analyst Jessica Fye maintains Denali Therapeutics (NASDAQ:DNLI) with a Overweight and raises the price target from...

'Biogen Is Pursuing More Dealmaking This Y...
06/27/2024 15:39:59

https://endpts.com/biogen-is-pursuing-more-dealmaking-this-year-with-plans-to-spend-up-to-8B/

stericycle-marinemax-agios-pharmaceuticals-and-other-big-stocks-moving-higher-on-monday

Stericycle, MarineMax, Agios Pharmaceutica...
06/03/2024 14:39:44

Denali Therapeutics Says FDA Has Selected ...
06/03/2024 12:09:50

DNL126 is an investigational enzyme replacement therapy designed to cross the BBB for the potential treatment of MPS IIIA (Sanf...

louisiana-pacific-posts-upbeat-results-joins-cricut-elanco-animal-american-public-education-and-other-big-stocks-moving-higher-on-wednesday

Louisiana-Pacific Posts Upbeat Results, Jo...
05/08/2024 15:11:22

Wedbush Maintains Outperform on Denali The...
05/08/2024 14:20:54

Wedbush analyst Laura Chico maintains Denali Therapeutics (NASDAQ:DNLI) with a Outperform and lowers the price target from $...

Stifel Maintains Hold on Denali Therapeuti...
05/08/2024 13:19:11

Stifel analyst Paul Mattels maintains Denali Therapeutics (NASDAQ:DNLI) with a Hold and lowers the price target from $26 to ...

HC Wainwright & Co. Reiterates Buy on Dena...
05/08/2024 13:11:18

HC Wainwright & Co. analyst Andrew Fein reiterates Denali Therapeutics (NASDAQ:DNLI) with a Buy and maintains $95 price ...

Denali Therapeutics Q1 EPS $(0.68) Beats $...
05/07/2024 20:50:23

Denali Therapeutics (NASDAQ:DNLI) reported quarterly losses of $(0.68) per share which beat the analyst consensus estimate of $...

Denali Therapeutics Completes Enrollment f...
05/01/2024 12:11:13

UBS Maintains Buy on Denali Therapeutics, ...
04/09/2024 16:05:59

UBS analyst Esther Rajavelu maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price target from $70 to $32.

Denali Therapeutics Inc Files Prospectus R...
03/22/2024 20:05:07

- SEC Filing

Goldman Sachs Maintains Buy Rating for Den...
02/29/2024 17:00:14

Goldman Sachs Maintains Buy on Denali Ther...
02/29/2024 14:57:12

Goldman Sachs analyst Salveen Richter maintains Denali Therapeutics (NASDAQ:DNLI) with a Buy and lowers the price target fro...